UKHSA (UK) · Jul 29, 2026
Guidance: Easy read guide to the MMRV vaccination
Easy read information on the MMRV vaccination which protects against measles, mumps, rubella and varicella.
Latest medical news · page 23
The latest headlines across every section, pulled from official and open-access sources.
Drugs@FDA · Jul 29, 2026
FDA approves Qlonilik (clonidine hydrochloride)
Original new drug approval. solution, oral. Sponsor: Cmp Dev Llc
FDA Enforcement · Jul 29, 2026
Drug recall: Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%), Sterile 0.4…
Lack of Assurance of Sterility — Rohto-Mentholatum (Vietnam) Co., Ltd. · Class II · Ongoing · 6076306 cartons
FDA Enforcement · Jul 29, 2026
Drug recall: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 10 Tablets (10 x 1) unit dose blisters per carton
Subpotent Drug — Major Pharmaceuticals · Class II · Ongoing · N/A
FDA Enforcement · Jul 29, 2026
Drug recall: Rohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0.012%, polysorbate 80 0.2%), Sterile, 0.4…
Lack of Assurance of Sterility — Rohto-Mentholatum (Vietnam) Co., Ltd. · Class II · Ongoing · 2910148 cartons
FDA Enforcement · Jul 29, 2026
Drug recall: Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg), 10 Tablets (10 x 1) unit dose blisters per carton
Subpotent Drug — Major Pharmaceuticals · Class II · Ongoing · N/A
FDA Enforcement · Jul 29, 2026
Drug recall: Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 100 Tablets (10 x 10 unit dose blisters) per carton
Subpotent Drug — Major Pharmaceuticals · Class II · Ongoing · N/A
FDA Enforcement · Jul 29, 2026
Drug recall: Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20…
Presence of Particulate Matter: Hair was found in products — Fresenius Kabi USA, LLC · Class II · Ongoing · 92,600 vials
FDA Enforcement · Jul 29, 2026
Drug recall: Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 100 Tablets (10 x 10 unit dose blisters) per carton
Subpotent Drug — Major Pharmaceuticals · Class II · Ongoing · N/A
FDA Enforcement · Jul 29, 2026
Drug recall: Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose blisters per carton
Subpotent Drug — Major Pharmaceuticals · Class II · Ongoing · N/A
FDA Enforcement · Jul 29, 2026
Drug recall: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 100 Tablets (10 x 10 unit dose blisters) per carton
Subpotent Drug — Major Pharmaceuticals · Class II · Ongoing · N/A
FDA Enforcement · Jul 29, 2026
Drug recall: Rohto Cooling Eye Drops Digi Eye (hypromellose 0.35%, tetrahydrozoline HCl 0.05%), Sterile, 0.4 FL OZ (13 mL)
Lack of Assurance of Sterility — Rohto-Mentholatum (Vietnam) Co., Ltd. · Class II · Ongoing · 65219 cartons
FDA Enforcement · Jul 29, 2026
Drug recall: Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL
Presence of Particulate Matter: Hair was found in products — Fresenius Kabi USA, LLC · Class II · Ongoing · 93,250 vials
FDA Enforcement · Jul 29, 2026
Drug recall: Rohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, 0.34 FL OZ (10 mL)
Lack of Assurance of Sterility — Rohto-Mentholatum (Vietnam) Co., Ltd. · Class II · Ongoing · 97201 cartons
FDA Enforcement · Jul 29, 2026
Drug recall: Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton
Subpotent Drug — Major Pharmaceuticals · Class II · Ongoing · N/A
FDA Enforcement · Jul 29, 2026
Drug recall: Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL (20 mg per mL), 25 Single Dose Vials, 5 mL per vial
Presence of Particulate Matter: Hair was found in products — Fresenius Kabi USA, LLC · Class II · Ongoing · 181,225 vials
FDA Enforcement · Jul 29, 2026
Drug recall: Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 80 0.2%), Sterile, TWIN…
Lack of Assurance of Sterility — Rohto-Mentholatum (Vietnam) Co., Ltd. · Class II · Ongoing · 499,673 cartons
FDA Enforcement · Jul 29, 2026
Drug recall: Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan — Asclemed USA Inc. · Class III · Ongoing · 18 kits
FDA Enforcement · Jul 29, 2026
Drug recall: Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications — Ascend Laboratories, LLC · Class II · Ongoing · 6,192 bottles
FDA Enforcement · Jul 29, 2026
Drug recall: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 10 Tablets (10 x 1) unit dose blisters per carton
Subpotent Drug — Major Pharmaceuticals · Class II · Ongoing · N/A
FDA Enforcement · Jul 29, 2026
Drug recall: Glycopyrrolate Oral Solution, 1 mg/5 mL, delivers 5 mL
Due to an out-of-specification result for an unidentified impurity detected during routine stability testing. — Precision Dose Inc. · Not Yet Classified · Ongoing · N/A
FDA Enforcement · Jul 29, 2026
Drug recall: Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg), 100 Tablets (10 x 10 unit dose blisters) per carton
Subpotent Drug — Major Pharmaceuticals · Class II · Ongoing · N/A
FDA Enforcement · Jul 29, 2026
Drug recall: Rohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0.03%, povidone 0.5%, propylene glycol…
Lack of Assurance of Sterility — Rohto-Mentholatum (Vietnam) Co., Ltd. · Class II · Ongoing · 1,278,457 cartons
FDA Enforcement · Jul 29, 2026
Drug recall: Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL
Presence of Particulate Matter: Hair was found in products — Fresenius Kabi USA, LLC · Class II · Ongoing · 37,250 vials